Lasse Ryhänen

2.1k total citations
45 papers, 1.8k citations indexed

About

Lasse Ryhänen is a scholar working on Pulmonary and Respiratory Medicine, Cell Biology and Genetics. According to data from OpenAlex, Lasse Ryhänen has authored 45 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 9 papers in Cell Biology and 9 papers in Genetics. Recurrent topics in Lasse Ryhänen's work include Protease and Inhibitor Mechanisms (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Connective tissue disorders research (7 papers). Lasse Ryhänen is often cited by papers focused on Protease and Inhibitor Mechanisms (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Connective tissue disorders research (7 papers). Lasse Ryhänen collaborates with scholars based in Finland, United States and Hong Kong. Lasse Ryhänen's co-authors include Jouni Uitto, Kari I. Kivirikko, Elaine Tan, Leena Ala‐Kokko, Henrik Anttinen, Darwin J. Prockop, Pasi Salmela, Leena Peltonen, Edward Zaragoza and Frej Stenbäck and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Lasse Ryhänen

45 papers receiving 1.6k citations

Peers

Lasse Ryhänen
M.T. Corvol France
A Oikarinen Finland
Masamichi Ishizaki Japan
P.G. NORRIS United Kingdom
Lala R. Chaudhary United States
Hiroaki Matsuno Japan
Marco Foschi Italy
Kenneth R. Cutroneo United States
Korsa Khan United Kingdom
Takaaki Tsunematsu Japan
M.T. Corvol France
Lasse Ryhänen
Citations per year, relative to Lasse Ryhänen Lasse Ryhänen (= 1×) peers M.T. Corvol

Countries citing papers authored by Lasse Ryhänen

Since Specialization
Citations

This map shows the geographic impact of Lasse Ryhänen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lasse Ryhänen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lasse Ryhänen more than expected).

Fields of papers citing papers by Lasse Ryhänen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lasse Ryhänen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lasse Ryhänen. The network helps show where Lasse Ryhänen may publish in the future.

Co-authorship network of co-authors of Lasse Ryhänen

This figure shows the co-authorship network connecting the top 25 collaborators of Lasse Ryhänen. A scholar is included among the top collaborators of Lasse Ryhänen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lasse Ryhänen. Lasse Ryhänen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaarteenaho–Wiik, Riitta, Essi Lakari, Vuokko L. Kinnula, et al.. (2006). Localization of precursor proteins and mRNA of type I and III collagens in usual interstitial pneumonia and sarcoidosis. The Histochemical Journal. 36(6-7). 437–446. 12 indexed citations
2.
Kerola, Tuomas, et al.. (2001). Inhibitory effect of the angiotensin converting enzyme inhibitors captopril and enalapril on the conversion of procollagen to collagen. Journal of Hypertension. 19(10). 1835–1839. 15 indexed citations
3.
Ryhänen, Lasse, Essi Lakari, Juha Risteli, et al.. (1999). Type III and Type I Procollagen Markers in Fibrosing Alveolitis. American Journal of Respiratory and Critical Care Medicine. 159(3). 818–823. 44 indexed citations
4.
Ryhänen, Lasse, Essi Lakari, Juha Risteli, et al.. (1999). Carboxyterminal propeptide of type I procollagen in ELF: elevation in asbestosis, but not in pleural plaque disease. European Respiratory Journal. 14(3). 560–560. 3 indexed citations
5.
Kinnula, Vuokko L., S Lähde, Juha Risteli, et al.. (1997). Propeptide levels of type III and type I procollagen in the serum and bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. European Respiratory Journal. 10(12). 2725–2730. 16 indexed citations
6.
Pääkkö, Paavo, Sisko Anttila, Raija Sormunen, et al.. (1996). Biochemical and morphological characterization of carbon tetrachloride-induced lung fibrosis in rats. Archives of Toxicology. 70(9). 540–552. 20 indexed citations
7.
Salmela, Pasi, Aarne Oikarinen, Olavi Ukkola, et al.. (1995). Improved metabolic control in patients with non‐insulin‐dependent diabetes mellitus is associated with a slower accumulation of glycation products in collagen*. European Journal of Clinical Investigation. 25(7). 494–500. 9 indexed citations
8.
Airaksinen, Juhani, Pasi Salmela, Markku K. Linnaluoto, et al.. (1993). Diminished arterial elasticity in diabetes: association with fluorescent advanced glycosylation end products in collagen. Cardiovascular Research. 27(6). 942–945. 157 indexed citations
9.
Kainulainen, Katariina, Lynn Y. Sakai, Anne H. Child, et al.. (1992). Two mutations in Marfan syndrome resulting in truncated fibrillin polypeptides.. Proceedings of the National Academy of Sciences. 89(13). 5917–5921. 100 indexed citations
10.
Palotie, Aarno, Kati Elima, Kathryn S.E. Cheah, et al.. (1989). PREDISPOSITION TO FAMILIAL OSTEOARTHROSIS LINKED TO TYPE II COLLAGEN GENE. The Lancet. 333(8644). 924–927. 128 indexed citations
11.
Pääkkö, Paavo, Raija Sormunen, Leila Risteli, et al.. (1989). Malotilate Prevents Accumulation of Type III pN-Collagen, Type IV Collagen, and Laminin in Carbon Tetrachloride-induced Pulmonary Fibrosis in Rats. American Review of Respiratory Disease. 139(5). 1105–1111. 15 indexed citations
12.
Pääkkö, Paavo, Leena Ala‐Kokko, & Lasse Ryhänen. (1987). A light microscopic and biochemical study of carbon tetrachloride‐induced pulmonary fibrosis in rats: the preventive effect of malotilate. European Journal of Clinical Investigation. 17(4). 340–346. 5 indexed citations
13.
Zaragoza, Edward, Lasse Ryhänen, Aarne Oikarinen, & Jouni Uitto. (1986). Inhibition of type II procollagen to collagen conversion by lysine derivatives and related compounds Mapping of the inhibitory structural features. Biochemical Pharmacology. 35(3). 532–535. 2 indexed citations
14.
Tan, Elaine, Lasse Ryhänen, & Jouni Uitto. (1983). Proline Analogues Inhibit Human Skin Fibroblast Growth and Collagen Production in Culture. Journal of Investigative Dermatology. 80(4). 261–267. 70 indexed citations
15.
Uitto, Jouni, et al.. (1982). Elastin in Diseases. Journal of Investigative Dermatology. 79(1). 160–168. 47 indexed citations
16.
Ryhänen, Lasse, et al.. (1982). Assay of Collagenase Activity by a Rapid, Sensitive, and Specific Method. Collagen and Related Research. 2(2). 117–130. 40 indexed citations
17.
Uitto, Jouni, et al.. (1982). Inhibition of Collagen Accumulation in Fibrotic Processes: Review of Pharmacologic Agents and New Approaches with Amino Acids and Their Analogues.. Journal of Investigative Dermatology. 79(s1). 113s–120s. 39 indexed citations
18.
Uitto, Jouni, Elaine Tan, & Lasse Ryhänen. (1982). Inhibition of Collagen Accumulation in Fibrotic Processes: Review of Pharmacologic Agents and New Approaches with Amino Acids and Their Analogues. Journal of Investigative Dermatology. 79(1). 113–120. 41 indexed citations
19.
Ryhänen, Lasse & Kari I. Kivirikko. (1974). Hydroxylation of lysyl residues in native and denatured protocollagen by protocollagen lysyl hydroxylase in vitro. Biochimica et Biophysica Acta (BBA) - General Subjects. 343(1). 129–137. 40 indexed citations
20.
Kivirikko, Kari I., Lasse Ryhänen, Henrik Anttinen, Paul Börnstein, & Darwin J. Prockop. (1973). Hydroxylation of lysyl residues in collagen by protocollagen lysyl hydroxylase in vitro. Biochemistry. 12(24). 4966–4971. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.T. Corvol Breakdown of academic impact, for papers by A Oikarinen Breakdown of academic impact, for papers by Masamichi Ishizaki Breakdown of academic impact, for papers by P.G. NORRIS Breakdown of academic impact, for papers by Lala R. Chaudhary Breakdown of academic impact, for papers by Hiroaki Matsuno Breakdown of academic impact, for papers by Marco Foschi Breakdown of academic impact, for papers by Kenneth R. Cutroneo Breakdown of academic impact, for papers by Korsa Khan Breakdown of academic impact, for papers by Takaaki Tsunematsu
Rankless by CCL
2026